Apollo Labs

Apollo Neuro develops and markets a wearable technology utilizing gentle vibrations to improve the body’s resilience to stress. This innovative device, worn on the wrist or ankle, signals the nervous system through touch, enhancing recovery, sleep, and focus. Its proprietary technology delivers specific frequencies that balance the autonomic nervous system, guiding users from 'fight or flight' towards rest and digest.

Co-founded by CEO Kathryn Fantauzzi and Dr. Dave Rabin, a neuroscientist and psychiatrist, Apollo Neuro emerged from the insight that physiological stress response is modulated through scientifically validated touch therapy. Dr. Rabin’s research into touch on the nervous system formed the scientific foundation, translating complex biological principles into a practical wellness solution.

Apollo Neuro’s product is designed for individuals managing daily stress, improving sleep, or enhancing recovery and cognitive performance. The company envisions a future where personalized, non-invasive neuro-wellness tools empower people to control their mental and physical states. Their objective is to broaden access to effective, drug-free methods for greater calm and resilience.